Dose-optimized Mydayis, a once-daily mixed salts of a single-entity amphetamine product, improved symptoms and executive function in adults with ADHD with or without sleep-quality impairments at baseline, according to a poster presented here. “[This] is the first study, to our knowledge, to inform clinicians of what they may expect in terms of stimulant treatment effects for ADHD when clients present with sleep complaints in addition to their ADHD,” Craig B. Surman, MD, of the department of psychiatry, Massachusetts General Hospital, told Healio Psychiatry.